In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Oramed gets $5.2mm via private placement

Executive Summary

Oramed Pharmaceuticals (oral insulin for diabetes) raised $5.2mm through the private placement of 8.67mm common shares priced at $0.60 each (a 5% discount) to twenty-nine accredited investors led by Montaur Capital Partners. Investors also received three-year warrants to buy another 4.26mm shares exercisable at $0.90 each.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies